This Strategic Insight looks into what core elements pharma needs to resolve forrare disease patients in order to reach them.
Cybercitizen Health® US is a study and strategic advisory service focused on helping clients understand digital behavior and needs across the osteoporosis patient experience, meet them with the…
Pharma should consider ‘EHR’ partnership opportunites over the next few years.
Taking the Pulse® Europe is a study and strategic advisory service focused on helping pharma companies understand how EU5 physicians learn about prescription treatments and interact with…
Taking the Pulse® Europe is a study and strategic advisory service focused on helping pharma companies understand how EU5 physicians learn about prescription treatments and interact with…
Taking the Pulse® Europe is a study and strategic advisory service focused on helping pharma companies understand how EU5 physicians learn about prescription treatments and interact with…
Taking the Pulse® Europe is a study and strategic advisory service focused on helping pharma companies understand how EU5 physicians learn about prescription treatments and interact with…
Medical nonadherence is an infamously expensive detriment to public health, costing pharmaceutical companies billions in lost revenues and leading to poorer patient outcomes. This report looks into…
This Strategic Insight looks into the latest online health info-seeking trends
Taking the Pulse® US is a study and strategic advisory service focused on helping life clients understand physician’s digital behavior and pain points, identify emerging content and service…
The ePharma Physician® Infectious Disease Physicians – Multichannel Study shows you how allergists learn about and access promotional, medical and practice support resources from pharma; how…
Taking the Pulse® US is a study and strategic advisory service focused on helping life clients understand infectious disease physicians digital behavior and pain points, identify emerging content…